News

Mike Gerards is currently working at The Maastricht Centre for Systems Biology (MaCSBio). His project focuses on the identification and functional characterization of novel genes involved in mitochondria (more specifically in mtDNA replication) and screening these genes for mutations in patients.

MODINT, AMIBM and CHILL have pulled together to set up an open innovation center for research into the development of fibers and yarns from biopolymers. The center will develop new textile production processes and –applications for this.

On 13 December, the Netherlands Organisation for Scientific Research (NWO) announced the research facilities that will be given highest priority status over the next four years in the Netherlands. Four facilities at Maastricht University, one of which shared by several clusters, are participating in...

The selective withdrawal of red blood cells as a treatment for haemochromatosis (iron overload) is an effective and patient-friendly alternative to phlebotomy (bloodletting) (PhD conferral Eva Rombout).

On 9 December 2016, leading politicians, scholars and interested parties followed the invitation of the municipality of Maastricht to attend the 25th anniversary of the Maastricht Treaty.

Leading up to the celebrations of the 25^th anniversary of the Maastricht Treaty, UM organised three 'Europe events'. A photo report of these events can be found at the bottom of this page.

A new detection technique – injecting tracers into ovarian ligaments – helps to carry out a sentinel lymph node procedure in ovarian cancer. This leads to greater accuracy in detecting lymph node metastases and also leads to fewer side effects for patients.

Following our message of 22 November 2016 the Executive Board decided to continue the collective health care insurance contract with CZ.

Employees, old-employees and their family who are interested in switching to CZ or another insurer need to terminate their current insurance policy, before 31...